Accordingly, we examined the role of T cells in NK cell therapy by depleting T cell subsets with anti-CD4 or/and anti-CD8 antibodies two days before primary tumor resection (Figure 3D Schema and Figure 3—figure supplement 1). Here, CD8A is linked to neoplasm.